Hospitals and clinics told regulators that switching to rebates in the 340B drug discount program would impose costs that ...
The Health Resources and Services Administration should abandon its consideration of a 340B rebate model pilot program ...
Hospital and pharma groups have sharpened their spears for the rematch on 340B rebates. | The administration's second stab ...
In February 2026, the Department of Justice filed amicus briefs supporting pharmaceutical manufacturers, asserting that Rhode ...
AHA urges HRSA to axe 340B model that would cost hospitals over $1 billion annually and increase administrative burdens.
New platform unifies data, automates workflows, and delivers predictive intelligence to help pharmacists and other health care providers maximize 340B performance, improve and accelerate patient ...
Opinion
CalMatters on MSNOpinion
Drug discount program is a lifeline for California’s most vulnerable
The 340B Drug Pricing Program cuts prescription drug costs for safety-net hospitals, which often invest the savings in patient care.
A federal court has struck down a 12-year-old Health Resources and Services Administration policy that restricted how certain 340B hospitals could make initial drug purchases, finding that the agency ...
The Washington Post yesterday published a letter to the editor from AHA President and CEO Rick Pollack responding to an April ...
The 340B Drug Pricing Program must be reformed to better patient health and disincentivize institutional profit-seeking ...
LYNN– At a recent State House briefing hosted by the Massachusetts Health & Hospital Association, healthcare leaders gathered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results